MedPath

The Second Hospital of Hebei Medical University

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

22

Active:0
Completed:9

Trial Phases

4 Phases

Early Phase 1:1
Phase 2:2
Phase 4:5
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials

Not Applicable
11 (57.9%)
Phase 4
5 (26.3%)
Phase 2
2 (10.5%)
Early Phase 1
1 (5.3%)

Venetoclax-Decitabine in Untreated Elderly/Unfit AML

Not Applicable
Recruiting
Conditions
AML, Adult
Interventions
Drug: VEN + DEC
First Posted Date
2025-08-12
Last Posted Date
2025-08-12
Lead Sponsor
The Second Hospital of Hebei Medical University
Target Recruit Count
39
Registration Number
NCT07117422
Locations
🇨🇳

The Second Hospital of Hebei Medical University, Hebei, China

Treatment of Acute Ischemic Stroke With Rt-PA Combined With Edaravone Dexborneol

Phase 4
Recruiting
Conditions
Acute Ischemic Stroke
Interventions
First Posted Date
2024-02-08
Last Posted Date
2024-02-08
Lead Sponsor
The Second Hospital of Hebei Medical University
Target Recruit Count
400
Registration Number
NCT06248242
Locations
🇨🇳

The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

Acupuncture Therapy Combined With Breathing Training for Patients With Stroke Complicated

Not Applicable
Completed
Conditions
Lung Diseases
Stroke
Interventions
Device: TCM acupuncture therapy
Drug: Conventional drug therapy
Behavioral: Rehabilitation therapy
Behavioral: Breathing training
First Posted Date
2023-07-05
Last Posted Date
2023-07-05
Lead Sponsor
The Second Hospital of Hebei Medical University
Target Recruit Count
72
Registration Number
NCT05930262
Locations
🇨🇳

Acupuncture Therapy Combined with Breathing Training for Patients with Stroke Complicated with Pulmonary Infection: A Clinical Study, Shijiazhuang, Hebei, China

Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme

Early Phase 1
Recruiting
Conditions
Glioblastoma Multiforme
Interventions
First Posted Date
2022-10-21
Last Posted Date
2022-10-21
Lead Sponsor
The Second Hospital of Hebei Medical University
Target Recruit Count
10
Registration Number
NCT05589961
Locations
🇨🇳

the Second Hospital of HeBei Medical University, Shijia Zhuang, Hebei, China

Effect of Left Atrial Appendage Velocity on Left Atrial Structure and Function After Radiofrequency Ablation Combined With Left Atrial Appendage Occlusion

Completed
Conditions
Left Atrial Function
Left Atrial Structure
Left Atrial Appendage Velocity
First Posted Date
2021-01-05
Last Posted Date
2021-03-18
Lead Sponsor
The Second Hospital of Hebei Medical University
Target Recruit Count
100
Registration Number
NCT04693871
Locations
🇨🇳

The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.